
















Elgar Peerschke - QuintilesIMS













  
























menu























About Us



Investor Relations



Services



Therapeutics



Insights



Careers



Events & Webinars



Investigators



Global Markets



Contact Us






Our Focus
Our History
Awards & Recognition
Sustainability
Ethics & Compliance
News
Media Contacts




Model-based Drug Development
Observational Research & Registries
Patient Engagement Services
Patient Recruitment
Payers & Providers
Phase I/IIa and Early Clinical Trials
Phase II/III Clinical Trials
Phase IIIb/IV Clinical Trials
Precision Medicine
Product Launch
Project Management
Real-World & Late Phase Strategy
Real-World Data & Analytics
Regulatory Affairs
Risk-based Monitoring
Safety & Pharmacovigilance
Site Start-Up
Specialty Clinical Associations & Patient Organization
Technology




Advisory Services
Biopharmaceutical R&D
Biopharmaceuticals Sales & Marketing
Biosimilars
Biostatistics
Brand & Scientific Communications
Cardiac Safety ECG Monitoring
Clinical Trial Planning & Design
Contract Sales
Data Management
Emerging Biopharma
Enriched Studies
Functional Service Provider
Generic Clinical Development
Late Phase Clinical Trials
Market Access
Market Entry/Exit
Marketed Product Maintenance
Medical Device & Diagnostics




Acute Care & Pain
Allergy & Respiratory
Cardiovascular
Central Nervous System
Diabetes
Immunology
Infectious Diseases
Internal Medicine
Oncology
Pediatrics
Public Health Interest
Rare Disease
Vaccines






About Us

Our Focus
Our History
Awards & Recognition
Sustainability
Ethics & Compliance
News
Media Contacts



Investor Relations


Services

Advisory Services
Biopharmaceutical R&D
Biopharmaceuticals Sales & Marketing
Biosimilars
Biostatistics
Brand & Scientific Communications
Cardiac Safety ECG Monitoring
Clinical Trial Planning & Design
Contract Sales
Data Management
Emerging Biopharma
Enriched Studies
Functional Service Provider
Generic Clinical Development
Late Phase Clinical Trials
Market Access
Market Entry/Exit
Marketed Product Maintenance
Medical Device & Diagnostics
Model-based Drug Development
Observational Research & Registries
Patient Engagement Services
Patient Recruitment
Payers & Providers
Phase I/IIa and Early Clinical Trials
Phase II/III Clinical Trials
Phase IIIb/IV Clinical Trials
Precision Medicine
Product Launch
Project Management
Real-World & Late Phase Strategy
Real-World Data & Analytics
Regulatory Affairs
Risk-based Monitoring
Safety & Pharmacovigilance
Site Start-Up
Specialty Clinical Associations & Patient Organization
Technology



Therapeutics

Acute Care & Pain
Allergy & Respiratory
Cardiovascular
Central Nervous System
Diabetes
Immunology
Infectious Diseases
Internal Medicine
Oncology
Pediatrics
Public Health Interest
Rare Disease
Vaccines



Insights


Careers


Events & Webinars


Investigators


Global Markets


Contact Us






Home
Our Leadership
Elgar Peerschke








Elgar 
Peerschke
President, Advisory Services
Elgar Peerschke was appointed president, Advisory Services in 2014.

Bringing more than 25 years of experience to Quintiles, Elgar joined Quintiles from Bain & Company, a global business consulting firm where he was a senior executive in its Global Healthcare Practice Group and a leading client service partner.  Prior to his work at Bain, Elgar spent more than a decade at McKinsey and Company in various leadership roles. 

Throughout his career, Elgar has focused on serving customers across the global healthcare industry, including many pharmaceutical and biotech companies. He has extensive leadership experience in strategy, business definition and models, research, clinical development, go-to-market strategies and post-merger integration. 

Elgar earned his bachelor’s degree in political science from Rutgers University and an MBA from New York University.









Connect with Elgar  Peerschke



Media Inquiries
Make your own media inquiry
MAKE AN INQUIRY
































Elgar Peerschke - Executive Bio, Compensation History, and Contacts - Equilar Atlas










 

















Log in | Sign up








x

 






As Featured In



















Elgar Peerschke
Chairman of the Board at The Female Health Company


View Full Profile
Are you Elgar Peerschke? Claim your profile


 


Sign up for Equilar Atlas and view Elgar Peerschke's full profile. 
With Equilar Atlas, you can:



IDENTIFY corporate executives in Elgar Peerschke's  network and community.
												FOLLOW changes in Elgar Peerschke's employment and money-in-motion.
												CONNECT with Elgar Peerschke through your network of contacts.
												








Elgar Peerschke's Executive Work History


Current


Chairman of the Board, 
The Female Health Company


Past
To view Elgar Peerschke's complete executive work history, sign up now
Age
60

 


Elgar Peerschke's Biography



Elgar Peerschke has served as Chairman of the Board and a director of the Company since October 2016. Mr. Peerschke previously served as a member of the board of directors of Aspen Park Pharmaceuticals, Inc. ("Aspen Park") from 2014 to October 2016. Since October 2016, Mr. Peerschke has served as Senior Advisor for the CEO and Senior Vice President Customer Relations at Quintiles ISH. Since February 2015, Mr. Peerschke has served as the President of Advisory Services at Quintiles Transnational Holdings Inc. and Quintiles Transnational Corp. From 2002 to 2014, he served as a Senior Partner in the New York and Zurich Offices at Bain & Company I ...
(Read More)

			Elgar Peerschke has served as Chairman of the Board and a director of the Company since October 2016. Mr. Peerschke previously served as a member of the board of directors of Aspen Park Pharmaceuticals, Inc. ("Aspen Park") from 2014 to October 2016. Since October 2016, Mr. Peerschke has served as Senior Advisor for the CEO and Senior Vice President Customer Relations at Quintiles ISH. Since February 2015, Mr. Peerschke has served as the President of Advisory Services at Quintiles Transnational Holdings Inc. and Quintiles Transnational Corp. From 2002 to 2014, he served as a Senior Partner in the New York and Zurich Offices at Bain & Company Inc., leading its Global Healthcare Practice Group and a Leading Client Service Partner. At Bain & Company Inc., he focused on the healthcare industry, providing insight and guidance in boardrooms of biopharmaceutical customers around the world. Before Bain & Company Inc., Mr. Peerschke was a Principal at McKinsey from 1990 to 2002, where he was an active leader in the North American pharmaceutical/medical products practice and led the e-health and clinical knowledge building initiatives. From 1988 to 1990, Mr. Peerschke worked at Wasserstein Perella, and from 1982 to 1988 he served as a Manager in the Financial Analysis Group at Union Pacific Corporation. Mr. Peerschke received an M.B.A. from New York University and BA in Political Science from Rutgers University. 

Director Qualifications 

Mr. Peerschke's achievements and wide-ranging experience in the pharmaceutical and medical products sectors led to the conclusion that he should serve as a director of the Company.
		
Source: The Female Health Company on 01/27/2017
		
	

 
 






Sign up for Equilar Atlas and view Elgar Peerschke's full profile. 



												By accessing Equilar Atlas, you can view bios, network, salary and wealth events
												of industry-leading executives like Elgar Peerschke. More specifically, you'll be able to:
												

IDENTIFY corporate executives in Elgar Peerschke's  network and community.
												FOLLOW changes in Elgar Peerschke's employment and money-in-motion.
												CONNECT with Elgar Peerschke through your network of conections.
												




View Full Profile


 








Search for over 360,000 executive profiles.





/bio



													Example: Elgar Peerschke


















Elgar Peerschke's Connections (10)





Sign up now to view Elgar Peerschke's 10 connections »









Michele Greco
Executive Vice President and Chief Financial Officer, The Female Health Company









Harry Fisch
Board Member, The Female Health Company









Martin C. Tayler
Executive Vice President, Global Operations, The Female Health Company









Lucy Lu
Board Member, The Female Health Company









Mario Eisenberger
Board Member, The Female Health Company









Mitchell S. Steiner
President, Chief Executive Officer and Director, The Female Health Company









Georges Makhoul
Board Member, The Female Health Company









Overton B. Parrish
Vice Chairman of the Board, The Female Health Company









Mary M. Frank
Board Member, The Female Health Company









David R. Bethune
Board Member, The Female Health Company








Popular Profiles






														Sign up now to view more executive profiles »
														









Thomas J. Lynch
Executive Chairman, TE Connectivity Ltd.









John J. Kita
EVP and CFO, A. O. Smith









Carl G. Annessa
EVP and COO, Hornbeck Offshore Services, Inc.









Elon R. Musk
CEO and Chairman, Tesla









Claiborne P. Deming
Chairman of the Board, Murphy Oil Corporation












×

Claim Your Profile Coming Soon
Interested in updating your biography and work history?
We're working on making it happen.
We'll email you when this feature is available.
Please enter valid email address.

Done


Thank you for your interest.
Ok






			Browse executive profiles:
			
				 A
			
				 B
			
				 C
			
				 D
			
				 E
			
				 F
			
				 G
			
				 H
			
				 I
			
				 J
			
				 K
			
				 L
			
				 M
			
				 N
			
				 O
			
				 P
			
				 Q
			
				 R
			
				 S
			
				 T
			
				 U
			
				 V
			
				 W
			
				 X
			
				 Y
			
				 Z



Equilar Homepage
Equilar Atlas
Equilar Insight
Equilar BoardEdge
Equilar Engage
Research Services
Knowledge Network
About Us
Login

� 2017 Equilar All Rights Reserved. Privacy Policy
1100 Marshall Street, Redwood City, CA 94063 | Phone (650) 241-6600 | Fax (650) 701-0993

























Elgar Peerschke, Newly Appointed President Of Quintiles Advisory Services (Photo: Business Wire) - TheStreet




































































 

 




















Action Alerts PLUS

Access AAPJim Cramer's Best Stocks for 2017Charitable Trust PortfolioMost Recent Trade Alert25 Investing Rules10 Trading Commandments

Real Money

Access RM25 Rules of InvestingJim Cramer's Best Stocks for 201710 CommandmentsStressed Out StocksCramer's Blog

Cramer
Mad Money
ETFs
Futures
Markets
Much More

BanksBiotechRetailTechPersonal FinanceRetirementFinancial Advisor CenterHow to SpendOptionsFixed IncomeVideo










Privacy Policy|Terms of Use© 1996- TheStreet Inc. All rights reserved
















                                DJIA
                            







                                NASDAQ
                            







                                S&P 500
                            






Market Data updated






Sign In




Your Membership(s)








Your Account





Account Preferences


Alerts


Newsletters







Subscribe





Logout



Subscribe

Access insights and guidance from our Wall Street pros. Find the product that's right for you.
Action Alerts PLUS
Action Alerts OPTIONS
Daily Swing Trade
Income Seeker
Quant Ratings
Real Money
Real Money Pro
Stocks Under $10
Top Stocks
Trifecta Stocks
Real Money Pro Portfolio
Chairman's Club
Compare All 
Chatter on the Street













































 








































Elgar Peerschke, Newly Appointed President Of Quintiles Advisory Services (Photo: Business Wire)






Business Wire




Feb 24, 2015 8:00 AM EST













 




























































  Quintiles today announced the appointment of Elgar Peerschke to serve as president, Advisory Services. In this role, Peerschke is responsible for leading Quintiles' Advisory Services organization and the continued development and delivery of its related services.   Elgar Peerschke, newly appointed president of Quintiles Advisory Services (Photo: Business Wire)   Bringing more than 25 years of experience to Quintiles, Elgar joins Quintiles from Bain & Company, a global business consulting firm, where he was a senior partner in its Global Healthcare Practice Group and a leading client service partner. Prior to Bain, Elgar spent more than a decade at McKinsey and Company in various leadership roles.  "Throughout his career, Elgar has focused on the healthcare industry, providing cutting-edge insight and guidance in boardrooms of biopharmaceutical customers around the world," said Tom Pike, chief executive officer, Quintiles. "His deep experience working on and developing innovative solutions for the biopharmaceutical industry combined with his extensive leadership expertise across a number of strategic and operational disciplines is a tremendous addition to an already strong Quintiles team."  Peerschke said, "I am extremely excited to be joining Quintiles and leading its world-class Advisory Services organization. The biopharmaceutical landscape continues to evolve at an incredible pace that requires innovative thinking, diverse expertise and flawless execution. I believe Quintiles - with its full-range of services - is uniquely positioned to succeed in this environment, enabling the connection of insights and superior delivery that improves our customers' probability of success."  Peerschke earned his bachelor's degree in political science from Rutgers University and his MBA from New York University.  About Quintiles  Quintiles (NYSE: Q), a Fortune 500 company, is the world's largest provider of biopharmaceutical development and commercial outsourcing services. With a network of more than 32,000 employees conducting business in approximately 100 countries, we helped develop or commercialize all of 2013's top- 100 best-selling drugs on the market. Quintiles applies the breadth and depth of our service offerings along with extensive therapeutic, scientific and analytics expertise to help our customers navigate an increasingly complex healthcare environment as they seek to improve efficiency and effectiveness in the delivery of better healthcare outcomes. To learn more about Quintiles, please visit www.quintiles.com.  Click here to subscribe to Mobile Alerts for Quintiles.   



 








 










































If you liked this article you might like













Parexel Is Discovering the Drugs of the Future
The midcap drug maker is finding growth as an outsourcing destination.



Chiradeep BasuMallick

Apr 10, 2017 4:44 PM EDT
























Analysts' Actions -- Arista, Capital One, Avis, Workday and More
Here are Friday's top research calls, including upgrades for Arista Networks, Capital One Financial and Workday, and a downgrade for Avis Budget.



TheStreet Staff

Feb 17, 2017 8:05 AM EST
























Analysts' Actions -- Eaton, Ford, Altria, Ralph Lauren and More
Here are Friday's top research calls, including an upgrade for Ford and downgrades for Eaton, Altria and Ralph Lauren.



TheStreet Staff

Feb 3, 2017 8:19 AM EST
























These 5 Health Care Stocks Are Breaking Out This Christmas
The health care sector has been a miserable performer lately -- but these five health trades are bucking the trend.



Jonas Elmerraji

Dec 20, 2016 6:02 AM EST








































 


















Advertising Partners



 






 






 






 


























 

























 































 


©1996-2017 TheStreet, Inc. All rights reserved.Action Alerts PLUS is a registered trademark of TheStreet, Inc.




Compare Brokers



 







 







 







 







 







 





















Elgar Peerschke, Newly Appointed President Of Quintiles Advisory Services (Photo: Business Wire) - TheStreet




































































 

 




















Action Alerts PLUS

Access AAPJim Cramer's Best Stocks for 2017Charitable Trust PortfolioMost Recent Trade Alert25 Investing Rules10 Trading Commandments

Real Money

Access RM25 Rules of InvestingJim Cramer's Best Stocks for 201710 CommandmentsStressed Out StocksCramer's Blog

Cramer
Mad Money
ETFs
Futures
Markets
Much More

BanksBiotechRetailTechPersonal FinanceRetirementFinancial Advisor CenterHow to SpendOptionsFixed IncomeVideo










Privacy Policy|Terms of Use© 1996- TheStreet Inc. All rights reserved
















                                DJIA
                            







                                NASDAQ
                            







                                S&P 500
                            






Market Data updated






Sign In




Your Membership(s)








Your Account





Account Preferences


Alerts


Newsletters







Subscribe





Logout



Subscribe

Access insights and guidance from our Wall Street pros. Find the product that's right for you.
Action Alerts PLUS
Action Alerts OPTIONS
Daily Swing Trade
Income Seeker
Quant Ratings
Real Money
Real Money Pro
Stocks Under $10
Top Stocks
Trifecta Stocks
Real Money Pro Portfolio
Chairman's Club
Compare All 
Chatter on the Street













































 








































Elgar Peerschke, Newly Appointed President Of Quintiles Advisory Services (Photo: Business Wire)






Business Wire




Feb 24, 2015 8:00 AM EST













 




























































  Quintiles today announced the appointment of Elgar Peerschke to serve as president, Advisory Services. In this role, Peerschke is responsible for leading Quintiles' Advisory Services organization and the continued development and delivery of its related services.   Elgar Peerschke, newly appointed president of Quintiles Advisory Services (Photo: Business Wire)   Bringing more than 25 years of experience to Quintiles, Elgar joins Quintiles from Bain & Company, a global business consulting firm, where he was a senior partner in its Global Healthcare Practice Group and a leading client service partner. Prior to Bain, Elgar spent more than a decade at McKinsey and Company in various leadership roles.  "Throughout his career, Elgar has focused on the healthcare industry, providing cutting-edge insight and guidance in boardrooms of biopharmaceutical customers around the world," said Tom Pike, chief executive officer, Quintiles. "His deep experience working on and developing innovative solutions for the biopharmaceutical industry combined with his extensive leadership expertise across a number of strategic and operational disciplines is a tremendous addition to an already strong Quintiles team."  Peerschke said, "I am extremely excited to be joining Quintiles and leading its world-class Advisory Services organization. The biopharmaceutical landscape continues to evolve at an incredible pace that requires innovative thinking, diverse expertise and flawless execution. I believe Quintiles - with its full-range of services - is uniquely positioned to succeed in this environment, enabling the connection of insights and superior delivery that improves our customers' probability of success."  Peerschke earned his bachelor's degree in political science from Rutgers University and his MBA from New York University.  About Quintiles  Quintiles (NYSE: Q), a Fortune 500 company, is the world's largest provider of biopharmaceutical development and commercial outsourcing services. With a network of more than 32,000 employees conducting business in approximately 100 countries, we helped develop or commercialize all of 2013's top- 100 best-selling drugs on the market. Quintiles applies the breadth and depth of our service offerings along with extensive therapeutic, scientific and analytics expertise to help our customers navigate an increasingly complex healthcare environment as they seek to improve efficiency and effectiveness in the delivery of better healthcare outcomes. To learn more about Quintiles, please visit www.quintiles.com.  Click here to subscribe to Mobile Alerts for Quintiles.   



 








 










































If you liked this article you might like













Parexel Is Discovering the Drugs of the Future
The midcap drug maker is finding growth as an outsourcing destination.



Chiradeep BasuMallick

Apr 10, 2017 4:44 PM EDT
























Analysts' Actions -- Arista, Capital One, Avis, Workday and More
Here are Friday's top research calls, including upgrades for Arista Networks, Capital One Financial and Workday, and a downgrade for Avis Budget.



TheStreet Staff

Feb 17, 2017 8:05 AM EST
























Analysts' Actions -- Eaton, Ford, Altria, Ralph Lauren and More
Here are Friday's top research calls, including an upgrade for Ford and downgrades for Eaton, Altria and Ralph Lauren.



TheStreet Staff

Feb 3, 2017 8:19 AM EST
























These 5 Health Care Stocks Are Breaking Out This Christmas
The health care sector has been a miserable performer lately -- but these five health trades are bucking the trend.



Jonas Elmerraji

Dec 20, 2016 6:02 AM EST








































 


















Advertising Partners



 






 






 






 


























 

























 































 


©1996-2017 TheStreet, Inc. All rights reserved.Action Alerts PLUS is a registered trademark of TheStreet, Inc.




Compare Brokers



 







 







 







 







 







 












    Elgar Peerschke | Quintiles Transnational Corp. | ZoomInfo.com 












Elgar Peerschke, Quintiles IMS Holdings, Inc. President, Advisory Services - REDBOOKS








































Brands, Marketers, Agencies. Search Less. Sell More.





/   SIGN IN

GET A FREE TRIAL   
CONTACT US: (800) 908-5395





















Elgar  Peerschke
President, Advisory Services, Quintiles IMS Holdings, Inc.

EMAIL: 
                      







              Real-time sales trigger feed - generated by REDBOOKS machine learning and natural language processing technology, tracking 800,000+ news sources to aggregate all new executives, job/role changes and news on decision makers, brands and agencies in the media/marketing industry.
              

              This sales feed is for Elgar  Peerschke at Quintiles IMS Holdings, Inc.. Elgar  Peerschke works as President, Advisory Services , acting in a Executive Management role .  Quintiles IMS Holdings, Inc. is a leader in Pharmaceuticals & Health Care Products .
              REDBOOKS tracks personnel changes for advertisers spending over $1 million annually.
              

              For more Executive Management leads or media/marketing prospecting automation, start a free trial now.
              

Recent Related News


08/12/2016:


The Female Health Company and Aspen Park Pharmaceuticals Name Members of New Board of Directors, to Serve Upon Completion of...

..... Bethune and Mary Margaret Frank, Ph.D.), three directors currently on APPs Board of Directors (Mitchell S. Steiner, M.D., Harry Fisch, M.D., and Elgar Peerschke, who will serve as Chairman) and three new directors (Georges Makhoul, Lucy Lu, M.D., and Mario Eisenberger, M.D.) below is additional information about each director.
The Veru Healthcare Board includes some of the most highly regarded and renowned individuals in their respective fields, said O.B. .....

People In This Article:
Elgar Peerschke
 





Learn more about Elgar  Peerschke  and 260,000+ key contacts

  Create targeted lead lists

  Gain insider knowledge with advanced machine  learning
  Real-time verified contact info



Enter Work Email:

Please enter email address.
 Please enter valid email address.









             Learn more about Elgar  Peerschke and 260,000+ key contacts
            



























First Name *

 Please enter first name.




Last Name *

 Please enter last name.






Company Name *

 Please enter company name.






Email *





Phone *

 Please enter phone number.
 Please enter 10 digits number.





What industry are you in? *  
                (Please select one the categories below)
Please enter value for the industry.




                     Media Sales
                  




                     Production
                  




                     Ad-Tech/Mar-Tech
                  




                     Sponsorship Sales
                  



  Agency New Business
                  



  Other:
                  




What is your role? *
                 
                 (Please select one the categories below)
Please enter value for the role.



  C-Suite
                  



  VP/Manager
                  



  Sales Rep
                  



  Other:
                  














Thank you for registering for a Free REDBOOKS.com Trial!
We are processing your request and will be in touch shortly to get you started!
For Immediate Assistance, please call us at (800) 908-5395 or email us at info@redbooks.com


























Home
Learn More
FREE Trial


Features




AD THINK Events
Thought Leadership Events
Top Advertiser Directory
Top Agency Directory



Add Your Agency
Update Your Agency
Agency Showcase
Advertising Associations
Creative Spotlight
Services and Suppliers


About Us
Blog
Contact Us
Jobs
Terms & Conditions
Privacy Policy





Customer Support
(800) 908-5395
Connect with us




















Copyright © 2017 Red Books LLC. All rights reserved














































Quintiles Appoints Elgar Peerschke as President of Advisory Services - QuintilesIMS













  
























menu























About Us



Investor Relations



Services



Therapeutics



Insights



Careers



Events & Webinars



Investigators



Global Markets



Contact Us






Our Focus
Our History
Awards & Recognition
Sustainability
Ethics & Compliance
News
Media Contacts




Model-based Drug Development
Observational Research & Registries
Patient Engagement Services
Patient Recruitment
Payers & Providers
Phase I/IIa and Early Clinical Trials
Phase II/III Clinical Trials
Phase IIIb/IV Clinical Trials
Precision Medicine
Product Launch
Project Management
Real-World & Late Phase Strategy
Real-World Data & Analytics
Regulatory Affairs
Risk-based Monitoring
Safety & Pharmacovigilance
Site Start-Up
Specialty Clinical Associations & Patient Organization
Technology




Advisory Services
Biopharmaceutical R&D
Biopharmaceuticals Sales & Marketing
Biosimilars
Biostatistics
Brand & Scientific Communications
Cardiac Safety ECG Monitoring
Clinical Trial Planning & Design
Contract Sales
Data Management
Emerging Biopharma
Enriched Studies
Functional Service Provider
Generic Clinical Development
Late Phase Clinical Trials
Market Access
Market Entry/Exit
Marketed Product Maintenance
Medical Device & Diagnostics




Acute Care & Pain
Allergy & Respiratory
Cardiovascular
Central Nervous System
Diabetes
Immunology
Infectious Diseases
Internal Medicine
Oncology
Pediatrics
Public Health Interest
Rare Disease
Vaccines






About Us

Our Focus
Our History
Awards & Recognition
Sustainability
Ethics & Compliance
News
Media Contacts



Investor Relations


Services

Advisory Services
Biopharmaceutical R&D
Biopharmaceuticals Sales & Marketing
Biosimilars
Biostatistics
Brand & Scientific Communications
Cardiac Safety ECG Monitoring
Clinical Trial Planning & Design
Contract Sales
Data Management
Emerging Biopharma
Enriched Studies
Functional Service Provider
Generic Clinical Development
Late Phase Clinical Trials
Market Access
Market Entry/Exit
Marketed Product Maintenance
Medical Device & Diagnostics
Model-based Drug Development
Observational Research & Registries
Patient Engagement Services
Patient Recruitment
Payers & Providers
Phase I/IIa and Early Clinical Trials
Phase II/III Clinical Trials
Phase IIIb/IV Clinical Trials
Precision Medicine
Product Launch
Project Management
Real-World & Late Phase Strategy
Real-World Data & Analytics
Regulatory Affairs
Risk-based Monitoring
Safety & Pharmacovigilance
Site Start-Up
Specialty Clinical Associations & Patient Organization
Technology



Therapeutics

Acute Care & Pain
Allergy & Respiratory
Cardiovascular
Central Nervous System
Diabetes
Immunology
Infectious Diseases
Internal Medicine
Oncology
Pediatrics
Public Health Interest
Rare Disease
Vaccines



Insights


Careers


Events & Webinars


Investigators


Global Markets


Contact Us






Home
Quintiles News
Quintiles Appoints Elgar Peerschke as President of Advisory Services









Press Release
February 24, 2015


Quintiles Appoints Elgar Peerschke as President of Advisory Services















RESEARCH TRIANGLE PARK, NC – February 24, 2015 – Quintiles today announced the appointment of Elgar Peerschke to serve as president, Advisory Services. In this role, Peerschke is responsible for leading Quintiles’ Advisory Services organization and the continued development and delivery of its related services.
Bringing more than 25 years of experience to Quintiles, Elgar joins Quintiles from Bain & Company, a global business consulting firm, where he was a senior partner in its Global Healthcare Practice Group and a leading client service partner. Prior to Bain, Elgar spent more than a decade at McKinsey and Company in various leadership roles.
“Throughout his career, Elgar has focused on the healthcare industry, providing cutting-edge insight and guidance in boardrooms of biopharmaceutical customers around the world,” said Tom Pike, chief executive officer, Quintiles. “His deep experience working on and developing innovative solutions for the biopharmaceutical industry combined with his extensive leadership expertise across a number of strategic and operational disciplines is a tremendous addition to an already strong Quintiles team.”
Peerschke said, “I am extremely excited to be joining Quintiles and leading its world-class Advisory Services organization. The biopharmaceutical landscape continues to evolve at an incredible pace that requires innovative thinking, diverse expertise and flawless execution.  I believe Quintiles – with its full-range of services – is uniquely positioned to succeed in this environment, enabling the connection of insights and superior delivery that improves our customers’ probability of success.”
Peerschke earned his bachelor’s degree in political science from Rutgers University and his MBA from New York University.
About Quintiles
Quintiles (NYSE: Q), a Fortune 500 company, is the world’s largest provider of biopharmaceutical development and commercial outsourcing services. With a network of more than 32,000 employees conducting business in approximately 100 countries, we helped develop or commercialize all of 2013’s top- 100 best-selling drugs on the market. Quintiles applies the breadth and depth of our service offerings along with extensive therapeutic, scientific and analytics expertise to help our customers navigate an increasingly complex healthcare environment as they seek to improve efficiency and effectiveness in the delivery of better healthcare outcomes. To learn more about Quintiles, please visit www.quintiles.com.
Contact:
Mari Mansfield, Media Relations (mari.mansfield@quintiles.com)
+1.919.998.2639

Karl Deonanan, Investor Relations (InvestorRelations@quintiles.com)
+1.919.998.2789


























Wharton Healthcare Business Conference










 
















Home
		         
		  Agenda
		         
		  Panels
		         
		  Keynotes
		          
		  Sponsors
		          
		  Logistics
		          
		Our Team
		       
		  Past Conferences
		          
		  Register















 2006 Conference
 Health Care
programs at Wharton
 2004 Conference




Panelists: Finance Panel
Elgar PeerschkeLeader of North America Healthcare Practice GroupBain & Company


Elgar Peerschke joined the New York office of Bain & Company in 2002.  He is the leader of Bain�s North America Healthcare Practice Group.
Over more than 15 years in consulting, Mr. Peerschke has focused on serving clients in the healthcare industry, primarily pharmaceutical and biotech companies.  His clients have also included PBMs, diagnostic/device companies and MCOs.  Over the course of that time, he directed numerous projects in strategy, organization, clinical development, and sales and marketing.  In addition, he has developed position papers on e/mHealth and the implication on clinical development and sales and marketing initiatives, and value creation in healthcare services.
His numerous projects include working with global pharmacos and biotech companies in rationalizing their clinical and in-line portfolio including BD/L&A implications, developing the best-of-both operating model in a global PMI initiative, developing clinical development plans for early stage potential blockbusters, and understanding the cost benefit trade-offs associated with the sequencing of indications for a novel compound.  He has also led teams in diagnosing sales force effectiveness opportunities, developing managed care strategies, and creating global launch and life-cycle management plans for potential blockbuster compounds.
Prior to joining Bain & Company, Inc. Mr. Peerschke was at McKinsey & Company for 13 years where he was a leader of the North American Pharmaceutical/Medical Products Practice. He holds an MBA from New York University and a BA from Rutgers University in Political Science.














	
		 © Copyright 2004 Wharton Healthcare Business Conference
		







 






Elgar Peerschke, President, Advisory Services, Quintiles


























&timesJavascript is disabled
























Market Profiles



Login
Sign up



Login


Sign up








 







 Edit

Person













Elgar Peerschke



President, Advisory Services
at
Quintiles


Location: New York, NY





Add to My Lists

Claim

Share


Copy the following code on your page/blog


Suggested widget size



Mobile



Desktop









Elgar Peerschke



President, Advisory Services
at
Quintiles


Location: New York, NY




Add to My Lists

Claim

Share


Copy the following code on your page/blog


Suggested widget size



Mobile



Desktop




Elgar Peerschke was appointed president, Advisory Services in 2014. Bringing more than 25 years of experience to Quintiles, Elgar joined Quintiles from Bain & Company, a global business consulting firm where he was a senior executive in its Global Healthcare Practice Group and a leading client service partner.  Prior to his work at Bain, Elgar spent more than a decade at McKinsey and Company in various leadership roles. Throughout his career, Elgar has focused on serving customers across the global healthcare industry, including many pharmaceutical and biotech companies. He has extensive leadership experience in strategy, business definition and models, research, clinical development, go-to-market strategies and post-merger integration.



3

Companies in Career





N/A

Related Markets





4

Colleagues





N/A

Related Investments








Alias
N/A



Industry
Pharmaceuticals




Tags
N/A




Topics of Influence












Web Site







N/A



























Careers








Achievements








Investments








Related People






 Edit
View all 



Elgar PeerschkeCareer (3)






2014




Quintiles



President, Advisory Services







2002 to 2015




Bain & Company



Partner







1990 to 2002




McKinsey & Company



Partner








Competencies










 Edit
View all 



Elgar PeerschkeEducation (2)










New York University













Rutgers University


Political Science









 Edit



Elgar PeerschkeAchievements and Recognitions





Add Milestone


No milestones has been recorded for Elgar Peerschke






 Edit



Elgar PeerschkeLinks





Add Link


No links has been recorded for Elgar Peerschke









Elgar PeerschkeInvestments/Acquisitions





No investments has been recorded for Elgar Peerschke









Elgar PeerschkeInvestments Representing Others





No investment reps has been recorded for Elgar Peerschke








Elgar PeerschkeRelated People








Colleagues at Quintiles







Mike  McDonnell

CFO
Oct-2015









Kevin Gordon

Chief Operating Officer
Oct-2015









Les Jordan

Director, Life Sciences IT Consulting
Oct-2013









Garrett Walker

SVP and CHRO
Jul-2013












View all 



Elgar PeerschkeRecommended Market Profiles (8)








Telemedicine

10,000 or More employees
19 companies








Social Media Marketing (ChiefMartec.com)

5,000 - 10,000 employees
111 companies








Big Data Universe List of Lists

10,000 or More employees
533 companies








Aggregated Marketing Technology

10,000 or More employees
2650 companies








Shared Economy Landscape (Jeremiah Owyang)

10,000 or More employees
267 companies








Inside Sales Landscape

10,000 or More employees
650 companies


















